Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for treatment of obsessive-compulsive disorder
IRCT2016020421745N4Phase 3Completed
- Sponsor
- Vice chancellor of research Shiraz University of Medical Sciences
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of escitalopram in obsessive compulsive disorder (OCD), sponsored by Vice chancellor of research Shiraz University of Medical Sciences. Started Apr 2016; status: completed.
02
Drugs
escitalopram
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT2016020421745N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016020421745N4.